The combination of dopa-responsive parkinsonian syndrome and motor neuron disease

Neurodegenerative Diseases

Volumn 6, Issue 3, 2009, Pages 95-101

  Pinkhardt, Elmar Hans ^a   Sperfeld, Anne Dorte ^a   Gdynia, Hans Jürgen ^a   Ludolph, Albert Christian ^a   Kassubek, Jan ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Amyotrophic lateral sclerosis; Idiopathic Parkinson's disease; Motor neuron disorders; Neurodegenerative disease; Parkinsonism

Indexed keywords

AMANTADINE; APOMORPHINE; LEVODOPA; PRAMIPEXOLE; RILUZOLE; ROPINIROLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BULBAR PARALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; DEGENERATIVE DISEASE; DEMENTIA; DRUG RESPONSE; DYSARTHRIA; DYSPHAGIA; ELECTROPHYSIOLOGY; FASCICULATION; FEMALE; GAIT DISORDER; HAND TREMOR; HUMAN; MALE; MOTONEURON; MOTOR NEURON DISEASE; MUSCLE ATROPHY; MUSCLE RIGIDITY; NERVE CELL DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPUA NEW GUINEA; PARKINSONISM; PRIORITY JOURNAL; QUADRIPLEGIA; SPASTIC PARAPLEGIA; SPASTIC PARESIS; TREATMENT OUTCOME; TREMOR;

ADULT; AGED; ANTIPARKINSON AGENTS; DOPAMINE AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; PARKINSONIAN DISORDERS; SYNDROME;

EID: 67649108912     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000207795     Document Type: Article

References (20)

1. Calne DB, Eisen A: Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship. Adv Neurol 1990; 53: 355-360.
2. Williams DR: Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern Med J 2006; 36: 652-660.
3. Williams TL, Shaw PJ, Lowe J, Bates D, Ince PG: Parkinsonism in motor neuron disease: case report and literature review. Acta Neuropathol 1995; 89: 275-283.
4. Qureshi AI, Wilmot G, Dihenia B, Schneider JA, Krendel DA: Motor neuron disease with parkinsonism. Arch Neurol 1996; 53: 987-991.
5. Davison C: Pallido-pyramidal disease. J Neuropathol Exp Neurol 1954; 13: 50-59.
6. Gibb WR, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
7. Brooks BR, Miller RG, Swash M, Munsat TL: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
8. Chad DA: Electrodiagnostic approach to the patient with suspected motor neuron disease. Neurol Clin 2002; 20: 527-555, viii.
9. Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ: Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2006;66:968-975.
10. Ben Hamida M, Hentati F, Ben Hamida C: Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. Brain 1990; 113: 347-363.
11. Sudo S, Fukutani Y, Matsubara R, Sasaki K, Shiozawa M, Wada Y, Naiki H, Isaki K: Motor neuron disease with dementia combined with degeneration of striatonigral and pallidoluysian systems. Acta Neuropathol 2002; 103: 521-525.
12. Spencer PS, Palmer VS, Ludolph AC: On the decline and etiology of high-incidence motor system disease in West Papua (southwest New Guinea). Mov Disord 2005; 20(suppl 12):S119-S126.
13. Gdynia HJ, Süssmuth SD, Lira S, Storch A, Ludolph A, Ludolph AC: Evaluation of offlabel usage of levodopa and apomorphine in amyotrophic lateral sclerosis: an observational study. Submitted.
14. Morris HR, Al-Sarraj S, Schwab C, Gwinn-Hardy K, Perez-Tur J, Wood NW, Hardy J, Lees AJ, McGeer PL, Daniel SE, Steele JC: A clinical and pathological study of motor neurone disease on Guam. Brain 2001; 124: 2215-2222.
15. Kokubo Y, Kuzuhara S: Neuroradiological study of patients with amyotrophic lateral sclerosis and parkinsonism-dementia complex on the Kii Peninsula of Japan. Arch Neurol 2003; 60: 1257-1261.
16. Winhammar JM, Rowe DB, Henderson RD, Kiernan MC: Assessment of disease progression in motor neuron disease. Lancet Neurol 2005; 4: 229-238.
17. Hideyama T, Momose T, Shimizu J, Tsuji S, Kwak S: A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis. Arch Neurol 2006; 63: 1719-1722.
18. Shintaku M, Oyanagi K, Kaneda D: Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: report of an autopsy case. Neuropathology 2007; 27: 295-299.
19. Waibel S, Reuter A, Malessa S, Blaugrund E, Ludolph AC: Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model. J Neurol 2004; 251: 1080-1084.
20. Imamura A, Wszolek Z, Uitti R: Neurodegenerative overlap syndrome: parkinsonism and motor neuron disorder. Mov Disord 2007; 22: 151-152.